Chilean government adopts national plan on dementia

07:12 EST 8 Nov 2017 | Alzheimer Disease International

8 November 2017 – The government of Chile has adopted a national plan on dementia. The plan is the 30th to be adopted worldwide, and includes key targets for improving awareness, access to care, support and treatment, research and risk reduction of dementia by 2025.

It is estimated that 180,000 people are living with dementia in Chile, resulting in a cost of care per person of almost USD $11,000 every year. The plan follows the examples of existing plans in Argentina, Costa Rica, Cuba, Mexico, Puerto Rico, Uruguay and the USA, and includes a budget of USD $5.5m a year for implementation.

Paola Barbarino, CEO of Alzheimer’s Disease International welcomed the adoption of the plan, noting the positive inclusion of the rights of people with dementia, and promotion of the dignity, inclusion and quality of life of those affected. She said, “The plan shows great vision and promise. I wish the Chilean government a successful roll out and implementation and a continuing positive relation with civil society organisations includingCorporación Alzheimer Chile, a member of ADI.”

National dementia plans remain the single most powerful tool to transform dementia care and support for people living with dementia and their care partners. The adoption of a global plan on dementia by the World Health Organization in May 2017 supports the message by ADI that all governments should develop a national response to dementia.

Where next?

Original Article: Chilean government adopts national plan on dementia


More From BioPortfolio on "Chilean government adopts national plan on dementia"

Quick Search


Relevant Topics

Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carrying out daily activities. There are about 820,000 peo...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...